PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China.\', \'Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. Electronic address: wangjuxian@imb.pumc.edu.cn.\', \'Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. Electronic address: shancen@imb.pumc.edu.cn.\', \'Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. Electronic address: wangyucheng@imb.pumc.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0223-5234(21)00471-210.1016/j.ejmech.2021.113622
?:hasPublicationType
?:journal
  • European journal of medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 34147744
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.266
?:rankingScore_hIndex
  • 127
?:title
  • Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34147744>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34147744>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all